These authors contributed equally to this work.
Blockade of CD47-mediated cathepsin S/protease-activated receptor 2 signaling provides a therapeutic target for hepatocellular carcinoma
Article first published online: 29 MAY 2014
© 2014 by the American Association for the Study of Liver Diseases
Volume 60, Issue 1, pages 179–191, July 2014
How to Cite
Lee, T. K.-W., Cheung, V. C.-H., Lu, P., Lau, E. Y. T., Ma, S., Tang, K. H., Tong, M., Lo, J. and Ng, I. O. L. (2014), Blockade of CD47-mediated cathepsin S/protease-activated receptor 2 signaling provides a therapeutic target for hepatocellular carcinoma. Hepatology, 60: 179–191. doi: 10.1002/hep.27070
Potential conflict of interest: Nothing to report.
The study was supported by the Hong Kong Research Grants Council Collaborative Research Fund (HKU 1/06C and HKU 7/CRF/09), Hong Kong Research Grants Council General Research Fund (HKU 771213M; to T.K.W.L.), and the National Natural Science Foundation of China (project no.: 81272440; to T.K.W.L.). I.O.L.N. is Loke Yew Professor in Pathology.
- Issue published online: 26 JUN 2014
- Article first published online: 29 MAY 2014
- Accepted manuscript online: 12 FEB 2014 07:45AM EST
- Manuscript Accepted: 7 FEB 2014
- Manuscript Revised: 30 JAN 2014
- Manuscript Received: 4 SEP 2013